Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fujikawa

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Journal of Gastroenterology and Hepatology|January 1, 1994
HCV infection and its clinical features in recipients of blood screened for HCV (C100-3) antibodyS Ito, H Honda, S Hibino, et al.
Transplantation Proceedings|August 1, 1990
Prevention of cyclosporine-associated arteriolopathy by p-aminobenzoic acid-N-D-mannoside sodium salt (K-MAP) in spontaneous hypertensive ratsS Teraoka, Y Yamaguchi, S Fujita, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 26, 2010
Clinical significance of CD133 and hypoxia inducible factor-1α gene expression in rectal cancer after preoperative chemoradiotherapyS Saigusa, K Tanaka, Y Toiyama, et al.
Transplantation Proceedings|October 1, 1987
Evaluation of intracellular energy status during liver preservation by 31P-NMR spectroscopyS Fuchinoue, S Teraoka, H Honda, et al.
Diabetes|January 1, 1989
Modulation of prostaglandin metabolism by K-MAP and prevention of toxic effect of cyclosporin on pancreatic islet cellsS Teraoka, T Kawai, T Babazono, et al.
Transplantation Proceedings|February 1, 1991
The changes in prostaglandins after segmental pancreatic transplantationT Kawai, S Teraoka, T Hayashi, et al.
Transplantation Proceedings|February 1, 1989
Cyclosporine-associated toxicity in pancreatic islet cells and its prevention by K-MAP in cyclosporine-treated animalsS Teraoka, T Kawai, Y Yamaguchi, et al.
European Journal of Immunology|October 1, 1989
Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II moleculesT Uchiyama, K Imanishi, S Saito, et al.
Annals of Surgical Oncology|April 2, 2014
Diagnostic value of computed tomography for staging of clinical T1 gastric cancerH Fujikawa, T Yoshikawa, S Hasegawa, et al.
Clinical and Experimental Immunology|June 1, 1987
Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxinT Uchiyama, Y Kamagata, X J Yan, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Journal of Gastroenterology and Hepatology|January 1, 1994
HCV infection and its clinical features in recipients of blood screened for HCV (C100-3) antibodyS Ito, H Honda, S Hibino, et al.
Transplantation Proceedings|August 1, 1990
Prevention of cyclosporine-associated arteriolopathy by p-aminobenzoic acid-N-D-mannoside sodium salt (K-MAP) in spontaneous hypertensive ratsS Teraoka, Y Yamaguchi, S Fujita, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 26, 2010
Clinical significance of CD133 and hypoxia inducible factor-1α gene expression in rectal cancer after preoperative chemoradiotherapyS Saigusa, K Tanaka, Y Toiyama, et al.
Transplantation Proceedings|October 1, 1987
Evaluation of intracellular energy status during liver preservation by 31P-NMR spectroscopyS Fuchinoue, S Teraoka, H Honda, et al.
Diabetes|January 1, 1989
Modulation of prostaglandin metabolism by K-MAP and prevention of toxic effect of cyclosporin on pancreatic islet cellsS Teraoka, T Kawai, T Babazono, et al.
Transplantation Proceedings|February 1, 1991
The changes in prostaglandins after segmental pancreatic transplantationT Kawai, S Teraoka, T Hayashi, et al.
Transplantation Proceedings|February 1, 1989
Cyclosporine-associated toxicity in pancreatic islet cells and its prevention by K-MAP in cyclosporine-treated animalsS Teraoka, T Kawai, Y Yamaguchi, et al.
European Journal of Immunology|October 1, 1989
Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II moleculesT Uchiyama, K Imanishi, S Saito, et al.
Annals of Surgical Oncology|April 2, 2014
Diagnostic value of computed tomography for staging of clinical T1 gastric cancerH Fujikawa, T Yoshikawa, S Hasegawa, et al.
Clinical and Experimental Immunology|June 1, 1987
Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxinT Uchiyama, Y Kamagata, X J Yan, et al.
Pageof 13